Cymat Technologies (CYM) AI Stock Analysis

• Market Cap: C$8.53M
• Dividend Yield: N/A
• Average Volume (3M): 118.58K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.09
• Revenue Growth: -25.74%
• EPS Growth: 2.28%
• Country: CA
• Employees: 11
• Sector: General
• Sector Strength: N/A
• Industry: Manufacturing - Metal Fabrication
• EPS (TTM): -0.01
• Shares Outstanding: 100,337,330
• 10 Day Avg. Volume: 20,030
• 30 Day Avg. Volume: 118,582
• PEG Ratio: 0.12
• Price to Book (P/B): -2.03
• Price to Sales (P/S): 2.58
• P/FCF Ratio: -5.85
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 40 Underperform
• Price Target: C$0.08 ▼(-32.50% Downside)
• Action: Downgraded Date: 01/04/26
• Date: Action: Downgraded 01/04/26

The score is primarily constrained by very weak financial performance (deep losses, cash burn, and a stressed balance sheet with negative equity). Technicals are only neutral and do not offset the fundamental risk, while valuation remains pressured due to negative earnings and no indicated dividend yield support.

Positive Factors

Proprietary product technology

Cymat’s core proprietary aluminum foam addresses impact mitigation, vibration damping and lightweight structural needs. This specialized technology creates defensible product differentiation, enabling long-term supply relationships in industries that require certified, engineered materials.

Demonstrated margin recoverability

Historical positive gross margin in 2025 shows the business can generate product-level profitability under better volume, mix or cost conditions. That implies operating leverage exists and margins can be restored if sales and production normalize, supporting a path to sustainable operations.

Structural end-market tailwinds

End markets like transportation and industrial safety prioritize lightweighting and energy absorption. Those secular trends are durable, creating a stable addressable market for Cymat’s materials and potential for multi-year commercial supply agreements with OEMs and tier suppliers.

Negative Factors

Stressed balance sheet

Negative equity and meaningful debt versus a small asset base materially constrain financial flexibility. This raises refinancing, covenant and liquidity risk, increases cost of capital, and makes the company sensitive to any further operational setbacks over the next several months.

Persistent cash burn

Sustained negative operating and free cash flow indicate the business currently consumes cash to run operations. This forces reliance on external financing or asset adjustments, reduces runway for commercial investment, and elevates dilution or insolvency risk absent corrective action.

Deep and worsening losses

Declining revenue and sharply negative margins signal structural profitability problems—either pricing, cost, or volume issues. Persistent large losses erode capital, limit reinvestment in product or sales, and undermine the company’s ability to secure long-term contracts or scale sustainably.

Cymat Technologies Business Overview & Revenue Model

Company Description

Cymat Technologies Ltd., a materials technology company, manufactures and sells stabilized aluminum foam products worldwide. The company provides architectural materials under the Alusion brand name; and automotive and blast mitigation products under the SmartMetal brand name. It serves defense and military, automotive and transportation, architectural, and other application. The company was incorporated in 2006 and is based in Mississauga, Canada.

How the Company Makes Money

Cymat Technologies generates revenue primarily through the sale of its Alusion® stabilized aluminum foam products to various industries, including construction, automotive, aerospace, and defense. The company capitalizes on its proprietary technology by licensing its manufacturing processes to partners, which provides a secondary revenue stream. Additionally, Cymat engages in strategic partnerships with companies within these sectors to enhance its market reach and product development, enabling it to secure contracts and expand its customer base. The company's earnings are also bolstered by ongoing research and development initiatives that aim to innovate and improve its product offerings, allowing it to meet the evolving needs of its clients.

Cymat Technologies Financial Statement Overview

Summary

Financials indicate severe strain: TTM revenue declined (-4.2%), gross margin turned negative (~-2.4%), losses are extremely large versus sales (net margin ~-222%), and both operating cash flow and free cash flow are materially negative (~-$2.75M and ~-$2.77M). The balance sheet is also stressed with negative equity (~-$3.8M) and meaningful debt (~$5.8M) on a small asset base, limiting flexibility and increasing refinancing/liquidity risk.

Income Statement

TTM (Trailing-Twelve-Months) results show deep and worsening profitability pressure: revenue declined (-4.2% growth) and gross profit turned slightly negative (gross margin ~-2.4%). Losses remain very large versus sales (net margin ~-222%), with negative EBIT and EBITDA margins as well. While the prior annual period (2025) had positive gross margin (~13.3%), the business is still structurally unprofitable with persistent net losses across the history provided.

Balance Sheet

The balance sheet is highly stressed with negative shareholders’ equity in TTM (about -$3.8M) and elevated debt (~$5.8M) relative to a small asset base (~$3.7M). Negative equity makes leverage risk materially higher and limits financial flexibility. Debt has also increased versus the most recent annual period (2025), reinforcing refinancing and liquidity sensitivity if operating performance does not improve.

Cash Flow

Cash generation is weak: TTM (Trailing-Twelve-Months) operating cash flow and free cash flow are both meaningfully negative (about -$2.75M and -$2.77M, respectively), implying continued cash burn. A positive free cash flow growth figure is a modest improvement signal, but it is from a negative base and does not change that the company is funding ongoing losses and operations with external capital or balance-sheet resources.

Breakdown	TTM	Jul 2025	Jul 2024	Jul 2023	Jul 2021	Jul 2020
Income Statement
Total Revenue	1.83M	3.71M	1.62M	3.05M	4.15M	1.69M
Gross Profit	-43.88K	494.39K	-412.85K	-270.42K	2.12M	373.27K
EBITDA	-2.48M	-1.91M	-3.34M	-5.45M	252.17K	-1.51M
Net Income	-4.06M	-3.37M	-4.27M	-6.05M	-543.00K	-1.81M
Balance Sheet
Total Assets	3.68M	2.76M	3.96M	4.16M	6.58M	1.86M
Cash, Cash Equivalents and Short-Term Investments	926.84K	354.03K	56.27K	324.05K	5.02M	251.58K
Total Debt	5.81M	5.58M	2.94M	2.28M	1.38M	1.06M
Total Liabilities	7.50M	7.49M	6.78M	4.77M	3.71M	2.75M
Stockholders Equity	-3.83M	-4.73M	-2.81M	-612.07K	2.88M	-889.52K
Cash Flow
Free Cash Flow	-2.77M	-1.64M	-2.26M	-3.49M	401.48K	-1.38M
Operating Cash Flow	-2.75M	-1.60M	-2.23M	-2.46M	432.92K	-1.33M
Investing Cash Flow	-20.13K	-37.52K	-31.32K	-1.03M	-31.44K	-47.92K
Financing Cash Flow	3.46M	1.93M	1.99M	1.18M	4.36M	1.45M

Cymat Technologies Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.12
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CYM, the sentiment is Negative. The current price of 0.12 is above the 20-day moving average (MA) of 0.10, above the 50-day MA of 0.11, and below the 200-day MA of 0.13, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 33.12 is Neutral, neither overbought nor oversold. The STOCH value of 16.67 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:CYM.

Cymat Technologies Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
DRX	74 Outperform	C$272.68M	5.00	16.89%	0.46%	-26.61%	-45.62%
Sector *	55 Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
USCU	50 Neutral	C$46.46M	-9.85	-162.83%	―	―	1.23%
IB	45 Neutral	C$23.05M	-7.71	-78.49%	―	―	―
MTS	45 Neutral	C$13.72M	-7.52	-92.01%	―	―	―
CYM	40 Underperform	C$8.53M	-2.37	―	―	-25.74%	2.28%